Next Article in Journal
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Next Article in Special Issue
Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism
Previous Article in Journal
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
Previous Article in Special Issue
Correction: Alfei, S.; Zuccari, G. Recommendations to Synthetize Old and New β-Lactamases Inhibitors: A Review to Encourage Further Production. Pharmaceuticals 2022, 15, 384
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(5), 531; https://doi.org/10.3390/ph15050531
Action Date Notes Link
article xml file uploaded 25 April 2022 15:10 CEST Original file -
article xml uploaded. 25 April 2022 15:10 CEST Update -
article pdf uploaded. 25 April 2022 15:10 CEST Version of Record https://www.mdpi.com/1424-8247/15/5/531/pdf-vor
article html file updated 25 April 2022 15:11 CEST Original file -
article xml file uploaded 6 May 2022 02:58 CEST Update -
article xml uploaded. 6 May 2022 02:58 CEST Update https://www.mdpi.com/1424-8247/15/5/531/xml
article pdf uploaded. 6 May 2022 02:58 CEST Updated version of record https://www.mdpi.com/1424-8247/15/5/531/pdf
article supplementary file uploaded. 6 May 2022 02:58 CEST - https://www.mdpi.com/1424-8247/15/5/531#supplementary
article html file updated 6 May 2022 03:00 CEST Update -
article html file updated 2 August 2022 20:45 CEST Update https://www.mdpi.com/1424-8247/15/5/531/html
Back to TopTop